https://kstockbriefing.com
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary SK Hynix will host an Investor Relations (IR) meeting via conference call on July 29, 2026, at 09:00 AM to announce its Q2 2026 business results and hold a Q&A session. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary SK Hynix disclosed the results of its third-party capital increase for issuing American Depositary Receipts (ADRs) overseas, with the actual issue amount finalized at KRW 39.89T. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Differences Between Provisional Figures…
![[Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-07-15](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has entered into a contract with a North American shipowner for the construction of two Very Large Crude Carriers (VLCCs) valued at approximately KRW 394.3B, representing 3.1% of its recent annual revenue. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up…
Read More “[Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-07-15” »
![[Disclosure] Celltrion (068270) – CT-P51 (Keytruda Biosimilar) Europe Phase 3 Early Termination & Voluntary Withdrawal of Trial Plan / 2026-07-14](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has decided on the early termination and voluntary withdrawal of its Phase 3 clinical trial plan in Europe for CT-P51, a biosimilar to Keytruda (an immuno-oncology drug). This stems from an adjustment in clinical and regulatory approval strategy following changes in global regulatory trends, while…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has submitted an application for Part 1 & Part 2 of a Phase 3 clinical trial protocol amendment to the European Medicines Agency (EMA) for CT-P44, a biosimilar to Darzalex (a treatment for multiple myeloma). The amendment involves adjusting the number of clinical trial participants…
![[Disclosure] Hanmi Semiconductor (042700) – Consolidated Financial Results (Provisional) (Fair Disclosure) / 2026-07-14](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-한미반도체-1.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor reported provisional Q2 2026 consolidated revenue of approximately KRW 251.2B and operating profit of approximately KRW 130.3B, representing quarter-on-quarter increases of 393.4% and 1,441.4%, respectively. 📊 [Summary of Key Disclosure Content and Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Discrepancies…
![[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-07-14](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화시스템.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems announced that it will hold an Investor Relations (IR) session via Conference Call and Web Casting at 14:00 on July 28, 2026, to present its Q2 2026 financial results and hold a Q&A session. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment…
Read More “[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2026-07-14” »
![[Disclosure] SK Square (402340) – Foreign Exchange Listing of Securities / 2026-07-13](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-SK스퀘어.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square’s major subsidiary, SK Hynix Inc., listed 177,900,000 American Depositary Shares (ADRs) representing 17,790,000 underlying common shares on the NASDAQ Stock Market (Nasdaq Global Select Market) on July 10, 2026. 📊 [Summary of Key Disclosure Facts & Figures] 1. Overview of Listed Securities 2. ADR…
Read More “[Disclosure] SK Square (402340) – Foreign Exchange Listing of Securities / 2026-07-13” »
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary 177,900,000 American Depositary Receipts (ADRs), representing 17,790,000 common shares of SK Hynix, have been listed on the U.S. Nasdaq Stock Market. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Overseas ADR Listing and Subsequent Domestic Listing Schedule This…
![[Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-13](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성전자.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics decided to dispose of 1,132,477 treasury shares worth approximately KRW 322.8B to grant long-term incentive bonuses directly to 928 executives and key employees. 📊 [Key Disclosure Contents & Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Treasury Stock Disposal Execution and…